FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:KDM2A-NIPAL3

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: KDM2A-NIPAL3
FusionPDB ID: 41726
FusionGDB2.0 ID: 41726
HgeneTgene
Gene symbol

KDM2A

NIPAL3

Gene ID

22992

57185

Gene namelysine demethylase 2ANIPA like domain containing 3
SynonymsCXXC8|FBL11|FBL7|FBXL11|JHDM1A|LILINADJ462O23.2|NPAL3
Cytomap

11q13.2

1p36.11

Type of geneprotein-codingprotein-coding
Descriptionlysine-specific demethylase 2ACXXC-type zinc finger protein 8F-box and leucine-rich repeat protein 11F-box/LRR-repeat protein 11[Histone-H3]-lysine-36 demethylase 1AjmjC domain-containing histone demethylation protein 1Ajumonji C domain-containing hNIPA-like protein 3
Modification date2020032020200313
UniProtAcc

Q9Y2K7

Main function of 5'-partner protein: FUNCTION: Histone demethylase that specifically demethylates 'Lys-36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36'. May also recognize and bind to some phosphorylated proteins and promote their ubiquitination and degradation. Required to maintain the heterochromatic state. Associates with centromeres and represses transcription of small non-coding RNAs that are encoded by the clusters of satellite repeats at the centromere. Required to sustain centromeric integrity and genomic stability, particularly during mitosis. Regulates circadian gene expression by repressing the transcriptional activator activity of CLOCK-ARNTL/BMAL1 heterodimer and RORA in a catalytically-independent manner (PubMed:26037310). {ECO:0000269|PubMed:16362057, ECO:0000269|PubMed:19001877, ECO:0000269|PubMed:26037310, ECO:0000269|PubMed:28262558}.

Q6P499

Main function of 5'-partner protein:
Ensembl transtripts involved in fusion geneENST idsENST00000398645, ENST00000529006, 
ENST00000308783, ENST00000526258, 
ENST00000530342, 
ENST00000003912, 
ENST00000339255, ENST00000358028, 
ENST00000428131, ENST00000488155, 
ENST00000374399, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score36 X 24 X 17=146887 X 8 X 5=280
# samples 507
** MAII scorelog2(50/14688*10)=-4.87656605875172
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(7/280*10)=-2
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: KDM2A [Title/Abstract] AND NIPAL3 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: KDM2A [Title/Abstract] AND NIPAL3 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)KDM2A(66888829)-NIPAL3(24766661), # samples:1
Anticipated loss of major functional domain due to fusion event.KDM2A-NIPAL3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM2A-NIPAL3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM2A-NIPAL3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM2A-NIPAL3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:66888829/chr1:24766661)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across KDM2A (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NIPAL3 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000398645KDM2Achr1166888829+ENST00000374399NIPAL3chr124766661+21569068642033389
ENST00000529006KDM2Achr1166888829+ENST00000374399NIPAL3chr124766661+17384884461615389

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000398645ENST00000374399KDM2Achr1166888829+NIPAL3chr124766661+0.0033447090.9966552
ENST00000529006ENST00000374399KDM2Achr1166888829+NIPAL3chr124766661+0.0036000760.9963999

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for KDM2A-NIPAL3

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
KDM2Achr1166888829NIPAL3chr12476666148814EPEEERIRYSQRLENLIGALLAIFGH
KDM2Achr1166888829NIPAL3chr12476666190614EPEEERIRYSQRLENLIGALLAIFGH

Top

Potential FusionNeoAntigen Information of KDM2A-NIPAL3 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KDM2A-NIPAL3_66888829_24766661.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B18:01LENLIGAL0.99220.71321220
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B52:01SQRLENLI0.95480.7726917
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B39:06QRLENLIGA0.9960.59751019
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B18:01LENLIGALL0.84910.70491221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B39:13LENLIGALL0.29760.8711221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:04IRYSQRLENL0.99990.779616
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:02IRYSQRLENL0.99990.6336616
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:05IRYSQRLENL0.99990.8794616
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:05QRLENLIGAL0.99980.57011020
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:05QRLENLIGALL10.5951021
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:04QRLENLIGALL10.50831021
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:14QRLENLIGA0.99950.59751019
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B73:01QRLENLIGA0.99840.53641019
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:05RYSQRLENL0.89070.965716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:29RYSQRLENL0.87690.9358716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:13RYSQRLENL0.87470.951716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:19RYSQRLENL0.87070.8407716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:67RYSQRLENL0.80450.9635716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:80RYSQRLENL0.80450.9635716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:10RYSQRLENL0.79670.9677716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:46RYSQRLENL0.72530.9399716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B39:08LENLIGALL0.43140.81551221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:14IRYSQRLENL0.99990.8273616
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B39:12QRLENLIGAL0.99770.74991020
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:05IRYSQRLENL0.99760.9572616
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:03IRYSQRLENL0.99590.9005616
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:03QRLENLIGAL0.99370.62511020
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B73:01SQRLENLIGA0.97190.5859919
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:03QRLENLIGALL0.99940.65571021
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B18:05LENLIGAL0.99220.71321220
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:08QRLENLIGA0.99940.56591019
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B40:04LENLIGALL0.99730.66651221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B18:05LENLIGALL0.84910.70491221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B18:08LENLIGALL0.84690.64821221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B18:06LENLIGALL0.81840.73791221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:02RYSQRLENL0.80450.9635716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B18:03LENLIGALL0.77580.69041221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:17RYSQRLENL0.77010.9621716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C07:04RYSQRLENL0.76390.9532716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C06:06RYSQRLENL0.57630.9846716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B18:11LENLIGALL0.48190.6471221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C14:02RYSQRLENL0.42220.956716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-C14:03RYSQRLENL0.42220.956716
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B39:02LENLIGALL0.37360.88141221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B41:03LENLIGALL0.32630.63421221
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:06IRYSQRLENL0.99990.7965616
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:09IRYSQRLENL0.99990.8571616
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:08IRYSQRLENL0.99990.7986616
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:10IRYSQRLENL0.99990.8675616
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:09QRLENLIGAL0.99980.58381020
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:10QRLENLIGAL0.99980.66881020
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B39:31QRLENLIGAL0.99840.74881020
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:06QRLENLIGALL10.52131021
KDM2A-NIPAL3chr1166888829chr124766661906HLA-B27:09QRLENLIGALL10.58171021

Top

Potential FusionNeoAntigen Information of KDM2A-NIPAL3 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KDM2A-NIPAL3_66888829_24766661.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-0820EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1104EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1106EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1117EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1117EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1117PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1125EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1135EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1138EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1141EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1143EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1144EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1146EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1147EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1150EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1152EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1152EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1152PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1153EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1154EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1154EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1154PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1156EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1158EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1160EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1177EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1178EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1183EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1184EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1188EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1189EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1189EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1189PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1192EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1311EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1318EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1332EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1342EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1348EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1375EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1376EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1376EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1381EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1389EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1394EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1394EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1405EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1405EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1405PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1408EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1408EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1408PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1411EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1412EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1414EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1414EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1418EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1418EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1418PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1423EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1423EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1423PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1433EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1436EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1436EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1442EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1443EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1443EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1443PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1444EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1444EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1445EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1445EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1445PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1456EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1456EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1456PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1459EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1459EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1459PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1462EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1462EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1462PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1464EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1464EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1470EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1472EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1472EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1473EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1475EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1478EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1481EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1482EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1484EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1491EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1491EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1491PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1495EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1495EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1496EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1496EEERIRYSQRLENLI217
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1496PEEERIRYSQRLENL116
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1499EERIRYSQRLENLIG318
KDM2A-NIPAL3chr1166888829chr124766661906DRB1-1499EEERIRYSQRLENLI217

Top

Fusion breakpoint peptide structures of KDM2A-NIPAL3

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3967IRYSQRLENLIGALKDM2ANIPAL3chr1166888829chr124766661906

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of KDM2A-NIPAL3

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3967IRYSQRLENLIGAL-7.9962-8.1096
HLA-B14:023BVN3967IRYSQRLENLIGAL-5.70842-6.74372
HLA-B52:013W393967IRYSQRLENLIGAL-6.83737-6.95077
HLA-B52:013W393967IRYSQRLENLIGAL-4.4836-5.5189
HLA-A11:014UQ23967IRYSQRLENLIGAL-10.0067-10.1201
HLA-A11:014UQ23967IRYSQRLENLIGAL-9.03915-10.0745
HLA-A24:025HGA3967IRYSQRLENLIGAL-6.56204-6.67544
HLA-A24:025HGA3967IRYSQRLENLIGAL-5.42271-6.45801
HLA-B44:053DX83967IRYSQRLENLIGAL-7.85648-8.89178
HLA-B44:053DX83967IRYSQRLENLIGAL-5.3978-5.5112
HLA-A02:016TDR3967IRYSQRLENLIGAL-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of KDM2A-NIPAL3

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
KDM2A-NIPAL3chr1166888829chr1247666611019QRLENLIGACAGAGATTGGAAAACCTGATTGGCGCC
KDM2A-NIPAL3chr1166888829chr1247666611020QRLENLIGALCAGAGATTGGAAAACCTGATTGGCGCCCTC
KDM2A-NIPAL3chr1166888829chr1247666611021QRLENLIGALLCAGAGATTGGAAAACCTGATTGGCGCCCTCTTG
KDM2A-NIPAL3chr1166888829chr1247666611220LENLIGALTTGGAAAACCTGATTGGCGCCCTC
KDM2A-NIPAL3chr1166888829chr1247666611221LENLIGALLTTGGAAAACCTGATTGGCGCCCTCTTG
KDM2A-NIPAL3chr1166888829chr124766661616IRYSQRLENLATTCGTTACAGCCAGAGATTGGAAAACCTG
KDM2A-NIPAL3chr1166888829chr124766661716RYSQRLENLCGTTACAGCCAGAGATTGGAAAACCTG
KDM2A-NIPAL3chr1166888829chr124766661917SQRLENLIAGCCAGAGATTGGAAAACCTGATT
KDM2A-NIPAL3chr1166888829chr124766661919SQRLENLIGAAGCCAGAGATTGGAAAACCTGATTGGCGCC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
KDM2A-NIPAL3chr1166888829chr124766661116PEEERIRYSQRLENLCCCGAAGAAGAAAGGATTCGTTACAGCCAGAGATTGGAAAACCTG
KDM2A-NIPAL3chr1166888829chr124766661217EEERIRYSQRLENLIGAAGAAGAAAGGATTCGTTACAGCCAGAGATTGGAAAACCTGATT
KDM2A-NIPAL3chr1166888829chr124766661318EERIRYSQRLENLIGGAAGAAAGGATTCGTTACAGCCAGAGATTGGAAAACCTGATTGGC

Top

Information of the samples that have these potential fusion neoantigens of KDM2A-NIPAL3

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
THCAKDM2A-NIPAL3chr1166888829ENST00000398645chr124766661ENST00000374399TCGA-EM-A3SU

Top

Potential target of CAR-T therapy development for KDM2A-NIPAL3

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000003912213101_1210325.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000003912213135_1550325.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000003912213171_1910325.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000003912213202_2220325.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000003912213240_2600325.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000003912213271_2910325.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000003912213300_3200325.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000000391221333_530325.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000000391221376_960325.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000035802818101_1210227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000035802818135_1550227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000035802818171_1910227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000035802818202_2220227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000035802818240_2600227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000035802818271_2910227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000035802818300_3200227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST000003580281833_530227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST000003580281876_960227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000374399112101_1210407.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000374399112135_1550407.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000374399112171_1910407.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000374399112202_2220407.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000374399112240_2600407.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000374399112271_2910407.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST00000374399112300_3200407.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000037439911233_530407.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000037439911276_960407.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000042813107101_1210227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000042813107135_1550227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000042813107171_1910227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000042813107202_2220227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000042813107240_2600227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000042813107271_2910227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST0000042813107300_3200227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST000004281310733_530227.0TransmembraneHelical
TgeneNIPAL3chr11:66888829chr1:24766661ENST000004281310776_960227.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to KDM2A-NIPAL3

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to KDM2A-NIPAL3

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource